文献速递神经肿瘤

利用5-ALA介导的声动力疗法诱导恶性胶质瘤凋亡增强抗肿瘤活性:高强度聚焦超声在5-ALA-SDT小鼠胶质瘤模型中的意义

Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
PubMed 文献 · J Neurosurg · 2018-01-19

该研究在U87、U251胶质瘤细胞及U251Oct-3/4胶质瘤干细胞样细胞中评估5-ALA-SDT的体外细胞毒性,并在胶质瘤移植小鼠中研究5-ALA-SDT联合高强度聚焦超声(HIFU)对肿瘤生长、生存及组织学的影响。5-ALA-SDT抑制细胞生长并诱导凋亡,其细胞毒作用依赖于活性氧(ROS)生成;联合HIFU可延长荷瘤小鼠生存(p < 0.05),靶区以坏死为主、靶周诱导凋亡,而周围正常脑组织保持完整。

要点

  • 5-ALA-SDT在U87、U251及U251Oct-3/4细胞中抑制生长并诱导凋亡。
  • 5-ALA-SDT的细胞毒作用依赖ROS生成,依达拉奉清除ROS后完全消除该效应。
  • 5-ALA-SDT联合HIFU延长荷瘤小鼠生存(p < 0.05),靶区坏死、靶周凋亡,周围正常脑组织完整。

核心结论

  • 5-ALA-SDT对恶性胶质瘤具有细胞毒性,其ROS生成被认为促进胶质瘤细胞凋亡。
  • 5-ALA-SDT联合HIFU在HIFU照射野靶区诱导肿瘤坏死、靶周诱导凋亡,而周围脑组织保持正常,使HIFU治疗小鼠较未治疗小鼠生存期更长。
  • 作者认为5-ALA-SDT联合HIFU可能为恶性胶质瘤提供一种创伤更小且肿瘤特异性的治疗,不仅针对肿瘤团块,也针对浸润性肿瘤细胞。

研究设计与样本

  • 体外研究在U87和U251胶质瘤细胞及U251Oct-3/4胶质瘤干细胞样细胞中评估5-ALA-SDT的细胞毒性。
  • 采用流式细胞术和TUNEL染色分析治疗相关凋亡,测量细胞内活性氧(ROS),并通过依达拉奉预处理分析ROS的作用。
  • 体内研究在胶质瘤移植小鼠中观察5-ALA-SDT联合高强度聚焦超声(HIFU)对肿瘤生长、生存及小鼠脑组织学的影响。

主要发现

  • 5-ALA-SDT抑制细胞生长并改变细胞形态,诱导细胞皱缩、空泡化和肿胀。
  • 流式细胞术分析和TUNEL染色表明5-ALA-SDT在所有胶质瘤中诱导凋亡性细胞死亡。
  • 5-ALA-SDT产生的ROS显著高于对照组,依达拉奉抑制ROS生成完全消除了5-ALA-SDT的细胞毒效应。
  • 体内研究中,5-ALA-SDT联合HIFU较对照组大幅延长荷瘤小鼠生存期(p < 0.05)。
  • 组织学上,5-ALA-SDT主要引起HIFU照射野靶区肿瘤组织坏死并诱导靶周肿瘤细胞凋亡,整个肿瘤的增殖活性明显降低,HIFU超声照射野周围正常脑组织保持完整。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVEHigh invasiveness of malignant gliomas frequently causes early local recurrence of the tumor, resulting in extremely poor outcome. To control such recurrence, novel therapies targeted toward infiltrating glioma cells around the tumor border are required. Here, the authors investigated the antitumor activity of sonodynamic therapy (SDT) combined with a sonosensitizer, 5-aminolevulinic acid (5-ALA), on malignant gliomas to explore the possibility for clinical use of 5-ALA-mediated SDT (5-ALA-SDT).METHODSIn vitro cytotoxicity of 5-ALA-SDT was evaluated in U87 and U251 glioma cells and in U251Oct-3/4 glioma stemlike cells. Treatment-related apoptosis was analyzed using flow cytometry and TUNEL staining. Intracellular reactive oxygen species (ROS) were measured and the role of ROS in treatment-related cytotoxicity was examined by analysis of the effect of pretreatment with the radical scavenger edaravone. Effects of 5-ALA-SDT with high-intensity focused ultrasound (HIFU) on tumor growth, survival of glioma-transplanted mice, and histological features of the mouse brains were investigated.RESULTSThe 5-ALA-SDT inhibited cell growth and changed cell morphology, inducing cell shrinkage, vacuolization, and swelling. Flow cytometric analysis and TUNEL staining indicated that 5-ALA-SDT induced apoptotic cell death in all gliomas. The 5-ALA-SDT generated significantly higher ROS than in the control group, and inhibition of ROS generation by edaravone completely eliminated the cytotoxic effects of 5-ALA-SDT. In the in vivo study, 5-ALA-SDT with HIFU greatly prolonged survival of the tumor-bearing mice compared with that of the control group (p < 0.05). Histologically, 5-ALA-SDT produced mainly necrosis of the tumor tissue in the focus area and induced apoptosis of the tumor cells in the perifocus area around the target of the HIFU-irradiated field. The proliferative activity of the entire tumor was markedly decreased. Normal brain tissues around the ultrasonic irradiation field of HIFU remained intact.CONCLUSIONSThe 5-ALA-SDT was cytotoxic toward malignant gliomas. Generation of ROS by the SDT was thought to promote apoptosis of glioma cells. The 5-ALA-SDT with HIFU induced tumor necrosis in the focus area and apoptosis in the perifocus area of the HIFU-irradiated field, whereas the surrounding brain tissue remained normal, resulting in longer survival of the HIFU-treated mice compared with that of untreated mice. These results suggest that 5-ALA-SDT with HIFU may present a less invasive and tumor-specific therapy, not only for a tumor mass but also for infiltrating tumor cells in malignant gliomas.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Suehiro S, Ohnishi T, Yamashita D, et al. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model. J Neurosurg. 2018. PMID: 29350596. doi:10.3171/2017.6.JNS162398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。